A protein called Daam2 helps to regulate the activity of cells in the brain that make myelin, the fatty covering…
Articles by Marisa Wexler, MS
A test that assesses the levels of 18 proteins in the blood and uses artificial intelligence algorithms can help to…
Noting that Aubagio (teriflunomide) continues to have “a robust impact on disability progression” in multiple sclerosis (MS) despite…
A new system that can use MRI scans to effectively measure myelin content in brain tissue may help assess…
Diagnosing primary progressive multiple sclerosis (PPMS) can be challenging, with obstacles ranging from ruling out other disorders to differentiating between…
The presence of lesions, or regions of damage, in a brain circuit tied to memory in stroke patients also associate…
Treatment with polysialic acid, a sugar molecule naturally made in the body, may be a promising approach to boost myelin…
Aubagio (teriflunomide) can significantly reduce the risk of developing multiple sclerosis (MS) among adults with signs of MS-like…
Researchers have shed new light on the molecular mechanisms that help immune cells get into the brain to drive inflammation…
People who experience a first attack of multiple sclerosis (MS)-like disease are less likely to experience long-term disability progression…
A higher quality diet is associated with reductions in certain types of brain lesions in multiple sclerosis (MS), but…
Immune cells in the skull’s bone marrow show distinct molecular profiles from those of other bones throughout the body, and…
An antibody biomarker may help to distinguish people with a disease that resembles multiple sclerosis (MS), but may actually…
A new imaging technique was able to detect inflammation in a mouse model of multiple sclerosis (MS) before disease…
Estimates of the prevalence of sexual dysfunction with multiple sclerosis (MS), as well of its risk factors, differ depending…
In people with relapsing forms of multiple sclerosis (MS), relapses that occur in the first few years after the…
Pro-inflammatory immune cells that can target the brain may be activated in a specific region of the intestine by certain…
Octave Bioscience has raised $30 million in financing to help accelerate commercialization efforts for its precision care program for…
A new artificial intelligence (AI) algorithm could help identify people at risk of developing multiple sclerosis (MS). “Our model’s…
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, has recommended that PB006,…
In multiple sclerosis (MS), inflammation leads to less energy production in nerve fibers by reducing the levels of enzymes…
Synaptogenix is teaming up with Cleveland Clinic for a Phase 1 clinical trial involving people with multiple sclerosis…
A first-of-its-kind study is aiming to determine whether older adults with multiple sclerosis (MS) can safely stop taking…
With a planned merger in the works, Frequency Therapeutics is no longer advancing its remyelination therapies for multiple…
Since their launch in the 2010s, the use of oral disease-modifying treatments (DMTs) for multiple sclerosis (MS) has increased…
A new formulation of Ocrevus (ocrelizumab), given as a 10-minute under-the-skin injection, was comparable to the approved intravenous version…
Inflammation in the membranes around the brain may trigger an inflammatory response that can spread into nearby brain tissue, a…
The biopharmaceutical company Imcyse has signed on to a new project that aims to use artificial intelligence (AI) to…
Treatment with estriol, a hormone that’s produced during pregnancy, reduced disease severity and promoted myelin repair in the cortex —…
The PoNS device — officially the Portable Neuromodulation Stimulator, designed to help improve walking ability in people with…